Controlling Microbial Growth in the Body: Antimicrobial Drugs

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Basic Vocabulary

This section introduces essential terms related to antimicrobial therapy, which are foundational for understanding how drugs are used to control microbial growth in clinical settings.

• Drugs: Chemical substances used to treat, prevent, or diagnose disease.

• Chemotherapeutic Agents: Chemical agents used to treat diseases, including infectious diseases and cancer.

• Antimicrobial Agents: Drugs that act against infections caused by microbes (bacteria, fungi, viruses, or protozoa).

• Semisynthetics/Synthetics: Semisynthetic drugs are chemically modified derivatives of natural antibiotics; synthetic drugs are entirely manufactured by chemical processes.

• Susceptible: Microorganisms that are inhibited or killed by a particular antimicrobial agent.

• Resistant: Microorganisms that are not inhibited or killed by a particular antimicrobial agent.

The History of Antimicrobial Agents

Key Historical Figures and Discoveries

The development of antimicrobial drugs revolutionized medicine, beginning in the early 20th century with several landmark discoveries.

• Paul Ehrlich (1854-1915): Developed the concept of the "magic bullet" and discovered Salvarsan, the first chemotherapeutic agent effective against syphilis.

• Alexander Fleming (1881-1955): Discovered Penicillium notatum mold produced penicillin, the first true antibiotic.

• Howard Florey: Worked with Fleming to purify and mass-produce penicillin.

• Gerhard Domagk (1895-1964): Discovered the first sulfa drug, Prontosil, effective against bacterial infections.

Example: The discovery of penicillin led to the development of many other antibiotics, drastically reducing deaths from bacterial infections.

Mechanisms of Antimicrobial Action

How Antimicrobial Drugs Work

Antimicrobial agents target specific structures or functions in microbes, minimizing harm to the host.

1. Inhibition of Cell Wall Synthesis: Drugs like penicillins and cephalosporins prevent the formation of peptidoglycan in bacterial cell walls, leading to cell lysis. Antifungals such as echinocandins inhibit fungal cell wall synthesis (β-glucan synthesis).

2. Inhibition of Protein Synthesis: Agents such as tetracyclines and macrolides bind to bacterial ribosomes, blocking translation and protein production.

3. Disruption of Cytoplasmic Membranes: Polymyxins and daptomycin disrupt bacterial membranes; antifungals like amphotericin B bind to ergosterol in fungal membranes, causing leakage of cell contents.

4. Inhibition of Metabolic Pathways: Sulfonamides inhibit folic acid synthesis in bacteria, a pathway not present in humans.

5. Inhibition of Nucleic Acid Synthesis: Quinolones and rifamycins interfere with DNA replication or RNA transcription in microbes.

6. Prevention of Virus Attachment, Entry, or Uncoating: Antiviral drugs can block viral attachment to host cells, entry, or uncoating, preventing infection.

Additional info: Selective toxicity is crucial—drugs must target microbial structures not found in human cells to minimize side effects.

Clinical Considerations in Prescribing Antimicrobial Drugs

Choosing and Evaluating Antimicrobial Agents

Several factors influence the selection and use of antimicrobial drugs in clinical practice.

• Ideal Antimicrobial Agent Characteristics:

  • High efficacy against the pathogen

  • Low toxicity to the host

  • Good tissue distribution

  • Low potential for resistance development

• Spectrum of Action:

  • Narrow-spectrum: Effective against a limited range of microbes (e.g., only Gram-positive bacteria).

  • Broad-spectrum: Effective against a wide variety of microbes (e.g., both Gram-positive and Gram-negative bacteria).

• Effectiveness Testing:

  • Diffusion Susceptibility Test (Kirby-Bauer Test): Measures the zone of inhibition around antibiotic disks on an agar plate to assess susceptibility.

  • Minimum Inhibitory Concentration (MIC) Test: Determines the lowest concentration of a drug that inhibits visible microbial growth.

• Routes of Administration:

  • External Infections: Topical application directly to the site of infection.

  • Internal Infections: Systemic administration via oral, intramuscular (IM), or intravenous (IV) routes.

  • Distribution: Drugs are transported to infected tissues via the bloodstream.

Safety and Side Effects

Risks Associated with Antimicrobial Therapy

While antimicrobial drugs are essential for treating infections, they can also cause adverse effects.

• Toxicity: Some drugs can damage organs (e.g., nephrotoxicity, hepatotoxicity).

• Therapeutic Index (TI): The ratio of the toxic dose to the therapeutic dose. A higher TI indicates a safer drug. $TI = \frac{\text{Toxic Dose}}{\text{Therapeutic Dose}}$

• Therapeutic Range/Window: The range of drug concentrations in which the drug is effective without being toxic.

• Allergies: Some individuals may develop allergic reactions to certain drugs (e.g., penicillin allergy).

• Disruption of Normal Microbiota: Broad-spectrum antibiotics can disrupt beneficial microbes, leading to secondary infections (e.g., Clostridioides difficile colitis).

Resistance to Antimicrobial Drugs

Development and Spread of Resistance

Microbial resistance to drugs is a growing concern in medicine, requiring careful management and new strategies.

• The Development of Resistance in Populations: Resistance arises through genetic mutations or acquisition of resistance genes via horizontal gene transfer.

• Mechanisms of Resistance:

  • Enzymatic destruction or inactivation of the drug (e.g., β-lactamases)

  • Alteration of drug targets

  • Decreased permeability or increased efflux of the drug

  • Bypassing the metabolic pathway targeted by the drug

• Drug Route: The method of drug administration can influence the development of resistance (e.g., subtherapeutic dosing increases risk).

• Multiple Resistance and Cross Resistance: Microbes may become resistant to multiple drugs, especially when resistance genes are located on the same plasmid. Cross-resistance occurs when resistance to one drug confers resistance to similar drugs.

• Retarding Resistance:

  • Use antimicrobials only when necessary

  • Complete prescribed courses

  • Use combination therapy

  • Develop new drugs and alternative therapies

Mechanism of Action	Example Drugs	Target Microbe
Inhibition of Cell Wall Synthesis	Penicillins, Cephalosporins	Bacteria
Inhibition of Protein Synthesis	Tetracyclines, Macrolides	Bacteria
Disruption of Cytoplasmic Membranes	Polymyxins, Amphotericin B	Bacteria, Fungi
Inhibition of Metabolic Pathways	Sulfonamides	Bacteria
Inhibition of Nucleic Acid Synthesis	Quinolones, Rifamycins	Bacteria
Prevention of Virus Attachment/Entry	Enfuvirtide, Oseltamivir	Viruses